
German researchers at University Hospital Erlangen have found that quercetin, a plant-derived compound, can slow the division of lung cancer cells and almost completely inhibit their ability to spread and form metastases. The findings were published in the Cell Death Discovery journal.
Quercetin is a naturally occurring compound found in various plant-based foods, including citrus fruits, buckwheat and onions.
Slowing the spread of cancer cells
The study was conducted in several stages, beginning with laboratory tests on cancer cells. Researchers exposed lung cancer cell cultures to varying concentrations of quercetin and monitored their responses.
The results showed that the compound slowed cell division, reduced intracellular oxidative stress and activated genes involved in programmed cell death, known as apoptosis.
Read also: The lycopene shift: Kazakhstan’s new low-cost supplement for cancer prevention.

The researchers also examined the cells’ ability to migrate. They found that higher concentrations of quercetin progressively reduced cancer cell migration. At the highest concentration tested, migration was almost completely halted — a potentially important factor in preventing metastasis.
Experiments on mice
The researchers then conducted experiments using mouse lung tissue samples and live laboratory mice. The findings suggested that quercetin may fight cancer through two complementary mechanisms: stimulating the immune system to mount a stronger attack on tumors while directly inhibiting cancer cell growth.
Experiments on live mice revealed another potential mechanism. Quercetin administration altered the composition of the animals’ gut microbiota, increasing the number of bacteria that produce short-chain fatty acids. These compounds entered the bloodstream and traveled to the lungs, where they further inhibited tumor growth. The mice subsequently showed a reduction in the number of tumor sites.
The study’s authors caution that, although the findings point to quercetin’s potential as a preventive and therapeutic agent, further research, including clinical trials in humans, is needed to establish its safety and effectiveness.